Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 118,630 | 89,379 | -23,989 | 73,787 | 70,451 |
| Operating Income | -118,630 | -89,379 | 23,989 | -73,787 | -70,451 |
| Other Income | 12,705 | 13,601 | 9,185 | 8,183 | 8,929 |
| Pre-tax Income | -105,925 | -75,778 | 33,174 | -65,604 | -61,522 |
| Income Tax | 234 | 190 | 170 | 108 | 139 |
| Net Income Continuous | -106,159 | -75,968 | 33,004 | -65,712 | -61,661 |
| Net Income | $-106,159 | $-75,968 | $33,004 | $-65,712 | $-61,661 |
| EPS Basic Total Ops | -1.46 | -1.05 | 0.62 | -1.12 | -1.07 |
| EPS Basic Continuous Ops | -1.46 | -1.05 | 0.63 | -1.12 | -1.07 |
| EPS Diluted Total Ops | -1.46 | -1.05 | 0.62 | -1.12 | -1.07 |
| EPS Diluted Continuous Ops | -1.46 | -1.05 | 0.63 | -1.12 | -1.07 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.35 | -0.49 | -0.37 | -0.36 |
| EBITDA(a) | $-121,471 | $-92,049 | $37,574 | $-76,722 | $-74,500 |